Invention Grant
- Patent Title: Inhibitors of tyrosine kinase 2 mediated signaling
-
Application No.: US16299485Application Date: 2019-03-12
-
Publication No.: US10508113B2Publication Date: 2019-12-17
- Inventor: Maria A. Argiriadi , Eric C. Breinlinger , Ellen Yulin Tsai Chien , Marlon D. Cowart , Kristine E. Frank , Michael M. Friedman , David J. Hardee , J. Martin Herold , Huaqing Liu , Wei Qiu , Marc J. Scanio , Michael R. Schrimpf , Thomas R. Vargo , Stacy A. Van Epps , Matthew P. Webster , Andrew J. Little , Matthew H. Katcher
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D471/04
Abstract:
Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4a, R4b, X1, X2, X3, X4, X5, nad n are as defined herein, pharmaeceutical compositions 2C X5, and n are as defined herein, pharmaceutical compositions comprising same, and methods of preparation and use.
Public/Granted literature
- US20190276450A1 INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING Public/Granted day:2019-09-12
Information query
